Market Cap 395.66M
Revenue (ttm) 43.47M
Net Income (ttm) -17.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.33
Profit Margin -41.25%
Debt to Equity Ratio 0.00
Volume 1,186,400
Avg Vol 1,379,820
Day's Range N/A - N/A
Shares Out 65.18M
Stochastic %K 8%
Beta 1.57
Analysts Strong Sell
Price Target $15.17

Latest News on CRMD

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 28, 2025, 3:01 AM EDT - 6 days ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future


CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 10:51 AM EDT - 8 days ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript


CorMedix Inc. Added to Nasdaq Biotechnology Index

Dec 19, 2024, 8:30 AM EST - 3 months ago

CorMedix Inc. Added to Nasdaq Biotechnology Index


CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 12:32 PM EDT - 5 months ago

CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript


CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 28, 2024, 1:33 PM EDT - 5 months ago

CorMedix 2.0: New Leadership, New Approval, New Focus


CorMedix Inc. Announces New Data at ASN Kidney Week 2024

Oct 24, 2024, 8:30 AM EDT - 5 months ago

CorMedix Inc. Announces New Data at ASN Kidney Week 2024


CorMedix Inc. Announces New Commercial Agreement

Sep 9, 2024, 10:52 AM EDT - 7 months ago

CorMedix Inc. Announces New Commercial Agreement


CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 2:08 PM EDT - 8 months ago

CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript


CorMedix Inc. Announces Outpatient Availability of DefenCath

Jul 3, 2024, 8:00 AM EDT - 9 months ago

CorMedix Inc. Announces Outpatient Availability of DefenCath


CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript

May 11, 2024, 5:48 PM EDT - 11 months ago

CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript


CorMedix Inc. to Participate in Two Upcoming Investor Conferences

May 10, 2024, 8:30 AM EDT - 11 months ago

CorMedix Inc. to Participate in Two Upcoming Investor Conferences


CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Apr 19, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath


CorMedix (CRMD) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 11:17 AM EDT - 1 year ago

CorMedix (CRMD) Q4 2023 Earnings Call Transcript


CorMedix Inc. Announces Commercial and Reimbursement Updates

Jan 30, 2024, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Commercial and Reimbursement Updates


CorMedix Inc. Announces Commercial and Operational Updates

Jan 8, 2024, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Commercial and Operational Updates


CorMedix Inc. Announces Appointment of Chief Legal Officer

Dec 15, 2023, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Appointment of Chief Legal Officer


CorMedix Inc. Announces Partnership With The Leapfrog Group

Dec 4, 2023, 8:30 AM EST - 1 year ago

CorMedix Inc. Announces Partnership With The Leapfrog Group


U.S. FDA approves CorMedix's antimicrobial drug

Nov 15, 2023, 10:11 AM EST - 1 year ago

U.S. FDA approves CorMedix's antimicrobial drug